Jounce Therapeutics, Inc.
SEC Filing List
JNCE CIK: 0001640455
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SC 13G/A | Amendment to Schedule filed to report ac... | Deep Track Capital, Lp | ADVISER COMPLIANCE ASSOCIATES LLC /fa | 02/14/2024 | |
| SC 13G | Schedule filed to report acquisition of ... | Opaleye Management Inc. | M2 COMPLIANCE LLC /fa | 02/09/2024 | |
| SC 13G/A | Amendment to Schedule filed to report ac... | Cowen Financial Products Llc | ADVISOR CONSULTANT NETWORK INC /fa | 02/02/2024 | |
| 15-12G | Notice of termination of registration of... | 05/15/2023 | |||
| 3 | Initial statement of beneficial ownershi... | DONNELLEY FINANCIAL SOLUTIONS File16 /fa | 05/05/2023 | ||
| SC 13D/A | Amendment to Schedule filed to report ac... | Tang Capital Partners Lp | SECUREX FILINGS /fa | 05/05/2023 | |
| 4 | Statement of changes in beneficial owner... | DONNELLEY FINANCIAL SOLUTIONS File16 /fa | 05/05/2023 | ||
| 4 | Statement of changes in beneficial owner... | Concentra Biosciences, Llc | DONNELLEY FINANCIAL SOLUTIONS File16 /fa | 05/05/2023 | |
| 25-NSE | Notification filed by national security ... | Nasdaq Stock Market LLC /fa | 05/04/2023 | ||
| 4 | Statement of changes in beneficial owner... | Salter-cid Luisa | Jounce Therapeutics, Inc. | 05/04/2023 | |
| No record found. | |||||
| Load More | |||||
